Private equity market AUM set to more than double, while secondaries (13.1%) predicted to see strongest annualized growth in forecast period of 2023 to 2029
LONDON, Sept. 18, 2024 (GLOBE NEWSWIRE) - ...
Presentations to highlight progress in development of IND candidates ZW220 and ZW251 based on Zymeworks'proprietary antibody-drug conjugate development platforms
VANCOUVER, British Columbia, Sept. 18...
STAMFORD, CT -- (BUSINESS WIRE) --
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vect...
